TLPH

Talphera Inc

0.79

-0.02-2.15%

Pre Market: 0.7934 0.00 0.00%08:00 02/18 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.7950/0.8108

TODAY RANGE0.7800-0.8220

VOL20

MARKET CAP36.98M

52 WEEK RANGE0.3800-1.570

AVG VOL (3M)327.71K

% TURNOVER0.13%

TURNOVER0

P/E (TTM)-2.0989

% RANGE5.18%

EPS(TTM)-0.3780

P/E(FORWARD)-2.1157

P/B1.886

BVPS0.4207

DIVIDEND--

P/S27.60

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP23.78M

SHARES OUTSTANDING46.61M

NEXT EARNINGS03/30-04/03

FREE FLOAT29.97M

LOT SIZE1

EX-DATE10/26/2022

News

Press Releases

Financial Reports

Profile

TipRanks·12/30/2025 13:45
Largest borrow rate increases among liquid names
TipRanks·11/14/2025 14:55
Maxim Group Remains a Buy on Talphera (TLPH)
TipRanks·11/14/2025 12:30
Analysts Conflicted on These Healthcare Names: Talphera (TLPH) and Bausch + Lomb Corporation (BLCO)
TipRanks·11/14/2025 00:19
Talphera, Inc. Earnings Call: Balancing Achievements and Challenges
TipRanks·11/13/2025 04:09
Talphera Reports Q3 2025 Financial Results and Updates
Seeking Alpha·11/13/2025 00:12
Talphera signals study completion in first half of 2026 as new site activations delay NEPHRO timeline
Seeking Alpha·11/12/2025 22:28
Talphera GAAP EPS of -$0.11 in-line
Reuters·11/12/2025 21:15
Talphera Raises $17 Million in Private Placement Led by CorMedix
Reuters·11/12/2025 21:09
Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing
Dow Jones·11/12/2025 21:05
Press Release: Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Seeking Alpha·11/12/2025 15:00
Here are the major earnings after the close Wednesday
Seeking Alpha·11/11/2025 22:35
Talphera Q3 2025 Earnings Preview
TipRanks·10/28/2025 20:36
Talphera files to sell 1.02M shares of common stock for holders
TipRanks·10/27/2025 22:43
Talphera’s Niyad Study: A Potential Game-Changer in Renal Therapy
TipRanks·10/24/2025 21:02
Talphera Holds Annual Meeting with Key Decisions

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+1.25%

946.47

Biogen Inc

BIIB

-0.46%

195.62

Amgen Inc

AMGN

+1.13%

373.36

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+8.11%

0.1000

Lilly Eli & Co

LLY

-0.38%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

-2.54%

2.30

Johnson & Johnson

JNJ

-0.05%

243.33

Abbvie Inc

ABBV

+0.59%

232.86

Zoetis Inc

ZTS

-0.86%

125.56

Gilead Sciences Inc

GILD

+0.19%

155.27

Novo-Nordisk A/S

NVO

-0.40%

49.37

Bristol-Myers Squibb Co

BMY

-0.64%

60.35

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.76%

27.37

Sanofi FR

SNY

+0.91%

46.43

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.88%

166.17

Dr Reddys Labs

RDY

+1.84%

14.40

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.